imiquimod
Generic: imiquimod
Labeler: teva pharmaceuticals usa, inc.Drug Facts
Product Profile
Brand Name
imiquimod
Generic Name
imiquimod
Labeler
teva pharmaceuticals usa, inc.
Dosage Form
CREAM
Routes
Active Ingredients
imiquimod 37.5 mg/g
Manufacturer
Identifiers & Regulatory
Product NDC
0093-3133
Product ID
0093-3133_38cf079b-29a3-e85d-e063-6294a90aece1
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA AUTHORIZED GENERIC
Application Number
NDA022483
Listing Expiration
2026-12-31
Marketing Start
2020-07-30
Pharmacologic Class
Mechanism of Action
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
00933133
Hyphenated Format
0093-3133
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
imiquimod (source: ndc)
Generic Name
imiquimod (source: ndc)
Application Number
NDA022483 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 37.5 mg/g
Packaging
- 1 BOTTLE, PUMP in 1 CARTON (0093-3133-31) / 7.5 g in 1 BOTTLE, PUMP
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["TOPICAL"], "spl_id": "38cf079b-29a3-e85d-e063-6294a90aece1", "openfda": {"nui": ["N0000009267", "N0000009269", "N0000000157"], "unii": ["P1QW714R7M"], "rxcui": ["967017"], "spl_set_id": ["9f2cbefd-f295-47e2-8a9e-3e7c5812c963"], "pharm_class_pe": ["Increased Cytokine Activity [PE]", "Increased Cytokine Production [PE]"], "pharm_class_moa": ["Interferon Inducers [MoA]"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PUMP in 1 CARTON (0093-3133-31) / 7.5 g in 1 BOTTLE, PUMP", "package_ndc": "0093-3133-31", "marketing_start_date": "20200730"}], "brand_name": "Imiquimod", "product_id": "0093-3133_38cf079b-29a3-e85d-e063-6294a90aece1", "dosage_form": "CREAM", "pharm_class": ["Increased Cytokine Activity [PE]", "Increased Cytokine Production [PE]", "Interferon Inducers [MoA]"], "product_ndc": "0093-3133", "generic_name": "imiquimod", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Imiquimod", "active_ingredients": [{"name": "IMIQUIMOD", "strength": "37.5 mg/g"}], "application_number": "NDA022483", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20200730", "listing_expiration_date": "20261231"}